Lucarini G, et al. - Authors investigated 54 laryngeal squamous cell carcinoma (LSCC) cases to analyze the clinical significance of CEACAM1 expression for the diagnosis/prognosis and decision making in LSCC during treatment. They observed a positive CEACAM subtype 1 (CEACAM1) expression in 50% of cases. They also noticed no significant differences in CEACAM1 expression in relation to age, gender, tumor size, and tumor but found correlated with tumor grade, development of local recurrence, node and distant metastasis.